Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03167086 · ClinicalTrials.gov registry record · NA
Single Session Pain Psychology Treatment: Comparative Efficacy & Mechanisms
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 263
- Enrollment target
NCT03167086: Completed NA study, sponsored by Stanford University.
NCT03167086 is a NA study that has completed, run by Stanford University. The registered enrollment target is 263 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03167086, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 263 participants
- Enrollment target
Study Summary
This study aims to compare the efficacy of a single session psychological treatment, "Empowered Relief" (ER), with the current standard of care, group Cognitive Behavioral Therapy (CBT) specifically on individuals with chronic low back pain who have pain-specific distress as indexed by pain catastrophizing scores.
Primary Outcome
Change in Trait Pain Catastrophizing (Trait PC) from baseline to 3 months post-treatment across all treatment groups
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy (CBT)
- BEHAVIORAL Health Education (HE)
- BEHAVIORAL "Empowered Relief" (ER)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 2017-06-08 |
| Est. Completion | 2020-08-18 |
| Phase | NA |
What the finished NCT03167086 record still lists
NCT03167086 is an interventional study that assigns participants to a tested intervention. The registered 263 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 3 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.
NCT03167086 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03167086 about?
NCT03167086 is a clinical study titled "Single Session Pain Psychology Treatment: Comparative Efficacy & Mechanisms". This study aims to compare the efficacy of a single session psychological treatment, "Empowered Relief" (ER), with the current standard of care, group Cognitive Behavioral Therapy (CBT) specifically on individuals with chronic low back pain who have pain-specific distress as indexed by pain catastro...
What is the current status of trial NCT03167086?
This trial is currently completed. It is a NA study. The enrollment target is 263 participants. The study started on 2017-06-08. Estimated completion is 2020-08-18.
What interventions are being tested in trial NCT03167086?
The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Health Education (HE) (BEHAVIORAL), "Empowered Relief" (ER) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03167086?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03167086's enrollment target sits among peer trials
263 396th of 2000 higher than 1,604 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04067336 · 263 participants · Phase 1
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
- NCT06234423 · 263 participants · Phase 1
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
- NCT06724627 · 263 participants · NA
Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting
- NCT04101669 · 264 participants · NA
RESET System Pivotal Trial (Rev F)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI